CLC Bio To Provide Custom Bioinformatics Platform for ACE BioSciences | GenomeWeb
NEW YORK (GenomeWeb News) – ACE BioSciences has tapped CLC Bio to develop a customized bioinformatics platform that will support its work in vaccine target discovery and validation, CLC Bio said today.
 
Under the terms of the agreement, CLC Bio will upgrade ACE BioSciences' current bioinformatics platform to ensure that the firm can compare, rank, and prioritize potential vaccine targets.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.